Woo Kim, MD, PhD

Dawonmedax Co. Ltd.

Seoul, SEO

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 28

2126 - Accurate Pharmacokinetic Estimation for BNCT: Comparing Planned and Delivered Doses in High-Grade Glioma Clinical Trial

Hall F

02:30pm - 04:00pm PT

Sep 29

2618 - A Multi-Centered, Radiation Dose Escalation, Phase 1 Clinical Trial on the Safety, Efficacy and Pharmacokinetics of BNCT in Patients with Recurrent High-Grade Gliomas

Hall F

08:00am - 09:00am PT